X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
4sc-202 (9) 9
apoptosis (5) 5
cancer (5) 5
index medicus (5) 5
cell growth (4) 4
expression (4) 4
gene expression (4) 4
histone deacetylase (4) 4
chemotherapy (3) 3
humans (3) 3
medical prognosis (3) 3
oncology (3) 3
stem cells (3) 3
tumors (3) 3
4sc‐202 (2) 2
animals (2) 2
apoptosis - drug effects (2) 2
benzamides - pharmacology (2) 2
brain cancer (2) 2
cancer cells (2) 2
cancer therapies (2) 2
cell line, tumor (2) 2
cell proliferation (2) 2
domatinostat (2) 2
epigenetics (2) 2
flow cytometry (2) 2
growth (2) 2
hdac inhibitor (2) 2
histone deacetylase inhibitors (2) 2
inhibition (2) 2
mice (2) 2
oral cancer (2) 2
oral squamous cell carcinoma (2) 2
pathway (2) 2
patients (2) 2
pediatrics (2) 2
xenograft model antitumor assays (2) 2
60 applied life sciences (1) 1
activated protein-kinase (1) 1
acy-957 (1) 1
adjuvant therapy (1) 1
akt (1) 1
allografts (1) 1
analysis (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
antitumor activity (1) 1
ask1 and cyclophilin-d (1) 1
atrt (1) 1
benzamides - administration & dosage (1) 1
benzoxazoles - administration & dosage (1) 1
benzoxazoles - pharmacology (1) 1
biochemistry & molecular biology (1) 1
bioinformatics (1) 1
biomedicine (1) 1
biophysics (1) 1
blotting, western (1) 1
brain tumors (1) 1
cancer biology (1) 1
cancer research (1) 1
cancer stem cell (1) 1
cancer stem cells (1) 1
carcinogenesis (1) 1
carcinogens (1) 1
carcinoma, hepatocellular - drug therapy (1) 1
carcinoma, hepatocellular - metabolism (1) 1
carcinoma, hepatocellular - pathology (1) 1
cardiovascular diseases (1) 1
cardiovascular system (1) 1
cell adhesion & migration (1) 1
cell biology (1) 1
cell culture (1) 1
cell cycle (1) 1
cell proliferation - drug effects (1) 1
cell survival (1) 1
cell viability (1) 1
central nervous system (1) 1
ceramide (1) 1
cerebellum (1) 1
chemo-sensitization and pre-clinical studies (1) 1
chemoresistance (1) 1
cholangiocarcinoma (1) 1
colon-cancer (1) 1
colorectal cancer (1) 1
colorectal neoplasms - pathology (1) 1
colorectal-cancer (1) 1
colorectal-cancer cells (1) 1
combined treatment (1) 1
communication (1) 1
cpi-0610 (1) 1
cyclophilin-d (1) 1
cytochrome c (1) 1
cytochrome p-450 (1) 1
cytotoxicity (1) 1
datasets (1) 1
death (1) 1
delta np63 (1) 1
development and progression (1) 1
diagnosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 59, pp. 99402 - 99413
Class I histone deacetylases (HDACs) inhibit expression of tumor suppressor genes by removing acetyl groups from histone lysine residues, thereby increasing... 
HDAC3 | Prognosis | Cholangiocarcinoma | Apoptosis | 4SC-202 | HEPATOCELLULAR-CARCINOMA CELLS | DIAGNOSIS | apoptosis | prognosis | P53 | CELL BIOLOGY | THERAPIES | COLORECTAL-CANCER CELLS | DIFFERENTIATION | HISTONE DEACETYLASE INHIBITORS | cholangiocarcinoma | EXPRESSION
Journal Article
Journal Article
Brain Sciences, ISSN 2076-3425, 11/2017, Volume 7, Issue 11, p. 147
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2019, Volume 102, Issue 2, pp. 163 - 173
Objectives Domatinostat (4SC‐202) is a selective class I histone deacetylase inhibitor (HDACi). This phase I study investigated safety, tolerability,... 
hematological malignancies | 4SC‐202 | HDAC inhibition | phase I study | domatinostat | epigenetics | 4SC-202 | HDAC INHIBITORS | IMMUNOTHERAPY | RESISTANCE | HEMATOLOGY | CANCER | Hypercalcemia | Histone deacetylase | Pharmacodynamics | Hematology | Toxicity | Liver | Antitumor activity | Pharmacokinetics | Patients | Embolism | Index Medicus
Journal Article
Cancer Letters, ISSN 0304-3835, 07/2019, Volume 454, pp. 108 - 119
Journal Article
Drugs of the Future, ISSN 0377-8282, 08/2015, Volume 40, Issue 8, pp. 549 - 555
The Sixth Annual EpiCongress focused on the latest advancements in translational epigenetic research. Speakers from leading academic groups and industrial... 
4SC-202 | ACY-957 | GSK-525762 | SP-2509 | LP99 | SP-2577 | GSK-591 | Nup-0148 | Tazemetostat | CPI-0610 | ORY-2001 | RVX-297 | Epigenome | KMe reader proteins | Resminostat | PHARMACOLOGY & PHARMACY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.